Ignite Creation Date:
2024-05-06 @ 7:41 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06094322
Status:
COMPLETED
Last Update Posted:
2024-04-10
First Post:
2023-10-17
Brief Title:
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging
Sponsor:
Centre Hospitalier Universitaire Amiens
Organization:
Centre Hospitalier Universitaire Amiens
Study Overview
Official Title:
Advanced DL-based T2w and DWI MR Sequences for Prostate Imaging
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DLRPRO
Brief Summary:
MR prostate exam is essential for the diagnosis workup and follow-up of prostate cancer It allows to detect subclinical prostate cancer following an increase in the level of PSA The investigators can score the lesion according to the PIRADS classification and obtain an estimate of lesion malignancy To perform this classification T2 and DWI sequences are essential
Detection and characterization of malignant lesion is important to address appropriate patient care pathway The purpose of this project is to evaluate novel deep learning DL T2-weighted TSE T2DL and Diffusion DWIDL sequences for prostate MR exam and investigate its impact on diagnostic examination time image quality and PI-RADS classification compared to standard T2-weighted TSE T2S and standard Diffusion DWIS sequences
Detection and characterization of malignant lesion is important to address appropriate patient care pathway The purpose of this project is to evaluate novel deep learning DL T2-weighted TSE T2DL and Diffusion DWIDL sequences for prostate MR exam and investigate its impact on diagnostic examination time image quality and PI-RADS classification compared to standard T2-weighted TSE T2S and standard Diffusion DWIS sequences
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None